Grandix Global Pharma Private Limited
About Grandix Global Pharma Private Limited
Data last updated:
Grandix Global Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2017PTC116820.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹19.14 Lakh. It was formerly known as Avaance Lifesciences Private Limited. It is led by directors Karnnanidhi Venneela Ramanar and Latha Subramanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 253 2nd Street Velan Nagar Valasaravakkam, Chennai, Tamil Nadu, India – 600087.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Grandix Global Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressNo. 253 2nd Street Velan Nagar Valasaravakkam, Chennai, Tamil Nadu, India – 600087
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Grandix Global Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Grandix Global Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Grandix Global Pharma Private Limited
FY 2025 filings availableGrandix Global Pharma Private Limited reported revenue of ₹465 (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 78% over five years, including a 98% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grandix Global Pharma Private Limited, buy the company report.
Board of directors of Grandix Global Pharma Private Limited
Grandix Global Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karnnanidhi Venneela Ramanar Also directs: Cholan Lifesciences Private Limited | Director | 29 May 2017 | 9 Years 5 Months | Current |
| Latha Subramanian | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Grandix Global Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grandix Global Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Grandix Global Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Grandix Global Pharma Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Latha Subramanian ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Grandix Global Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U51909TN2017PTC116820.
Grandix Global Pharma has 2 current directors:
- Karnnanidhi Venneela Ramanar - Director
- Latha Subramanian - Director
The latest financial statements of Grandix Global Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Grandix Global Pharma is U51909TN2017PTC116820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grandix Global Pharma was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
Latha Subramanian ceased to be Additional Director on 29 Sep 2024. Latha Subramanian was appointed as Director on 01 Apr 2024. Venkataraghavan Sourirajan ceased to be Director on 01 Apr 2024. Grandix Global Pharma has 5 board changes on record in total.
The registered office of Grandix Global Pharma is at No. 253 2nd Street Velan Nagar Valasaravakkam, Chennai, Tamil Nadu, India – 600087.
Grandix Global Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Grandix Global Pharma is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Grandix Global Pharma was formerly known as Avaance Lifesciences Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
